by Brandon Roberts, Annie Waldman and Pratheek Rebala, illustrations by Sam Green for ProPublica
2025.08.21
75% relevant
Less than five years post-pandemic, infectious-disease capacity and outbreak readiness are being hollowed, echoing the boom–bust pattern where success narratives trigger cuts that later raise mortality and costs. The article adds early-warning signs: reduced clinical trials, fewer inspections, and labs struggling to maintain basic vector research.
Fiona Spooner
2025.06.30
100% relevant
The article details Congress ending TB funding in 1972 and the subsequent U.S. and global TB resurgence tied to HIV, revealing the backfire of victory narratives.